CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Bacitracin Ophthalmic Ointment
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2025-03-03. Latest FDA row update: 2026-06-01.
FDA lists 1 package records, with companies: Padagis US LLC. Package NDCs: 0574-4022-35.
FDA shortage reason: Discontinuation of the manufacture of the drug
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Padagis US LLC | 0574-4022-35 | Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35) | Unavailable | 2026-06-01 |
Source facts
Grouped generic ingredient: Bacitracin Ophthalmic Ointment · 1 package records
Therapeutic categories: Anti-Infective, Ophthalmology
Dosage forms: Ophthalmic Ointment
Routes: Not stated
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.